Frequently Asked Questions
Have a different question and can't find the answer you're looking for?
Contact us and we'll get back to you as soon as we can.
We are currently working on a suitable process for getting access to our controlled set and do not have an anticipated date for completing it. Please keep checking our website to learn when it is out.
Note that this is an ongoing study and we are releasing data progressively as it is being collected. Our next release is planned towards the end of Fall 2024 with data from approximately 1,000 participants. Another release will likely be made a year later before the final release with data from 4,000 participants is made during Fall or Winter 2026.
You should receive the link typically within 2 weeks if not sooner depending on the number of requests we receive during that time. If you have any issues or questions regarding your data download request, please contactAI-READI Data Access Committee.
Currently, the dataset does not include EHR data, but this may be added in future releases. Patient visit summaries are not planned to be shared. A version of the dataset with PHI data is under consideration, but details and a release timeline are not yet available.
Medication data, including diabetes medications, is part of the protected dataset and is not currently available for general access.
The dataset does not include grading data for images, but the images themselves are available for analysis.
The dataset includes information on the number of participants and various data points. Details about the dataset's structure and any available longitudinal data can be found in the documentation.
Participants were not required to fast before their blood tests due to practical and health considerations. However, they were asked to report how long it had been since their last meal before the blood draw, and this information is included in the dataset.